Company Overview - Zhuzhou Times New Material Technology Co., Ltd. is located in Hunan Province, established on May 24, 1994, and listed on December 19, 2002. The company focuses on the research and engineering application of polymer materials, primarily serving industries such as rail transit, wind power generation, automotive, and high-performance polymer materials [1][2]. Financial Performance - For the first half of 2025, the company achieved operating revenue of 9.256 billion yuan, representing a year-on-year growth of 6.87%. The net profit attributable to shareholders was 303 million yuan, showing a significant increase of 36.66% [2]. - Since its A-share listing, the company has distributed a total of 1.106 billion yuan in dividends, with 442 million yuan distributed over the past three years [3]. Stock Performance - As of September 15, the company's stock price decreased by 2.01%, trading at 14.65 yuan per share, with a total market capitalization of 13.642 billion yuan. The stock has seen a year-to-date increase of 16.33%, but a decline of 3.43% over the last five trading days [1]. - The stock's trading volume on September 15 was 150 million yuan, with a turnover rate of 1.25%. The net outflow of main funds was 512,500 yuan, while large orders accounted for 21.36% of purchases and 18.79% of sales [1]. Business Segmentation - The company's main business revenue composition is as follows: wind power generation (40.63%), automotive products (35.18%), rail transit (11.67%), industrial and engineering (9.51%), new materials and others (2.38%), and other supplementary sources (0.63%) [1]. Shareholder Information - As of June 30, 2025, the number of shareholders increased to 31,300, with an average of 25,853 circulating shares per person, a decrease of 1.98% from the previous period [2]. - Notably, Hong Kong Central Clearing Limited and Bosera Theme Industry Mixed Fund (160505) have exited the top ten circulating shareholders [3]. Industry Classification - The company belongs to the machinery equipment sector, specifically in the rail transit equipment sub-sector, and is associated with concepts such as offshore wind power, wind energy, high-speed rail, new materials, and mid-cap stocks [2].

Core Viewpoint - The stock price of Kanda has shown a significant increase of 24.77% year-to-date, with recent fluctuations indicating a mixed performance in the short term [2]. Company Overview - Kanda Electronics Technology Co., Ltd. was established on July 30, 1998, and listed on December 27, 2019. The company is based in Shenzhen, Guangdong Province, and specializes in providing products, services, and system solutions in the rail transit sector [2]. - The main revenue composition includes: 64.63% from rail transit signal control systems, 23.90% from lightning protection and intelligent diagnosis, 6.64% from switch snow melting, 4.73% from system integration, and 0.11% from other sources [2]. Financial Performance - For the first half of 2025, Kanda achieved operating revenue of 160 million yuan, representing a year-on-year growth of 12.27%. However, the net profit attributable to shareholders decreased by 7.99% to 51.69 million yuan [2]. - Since its A-share listing, Kanda has distributed a total of 400 million yuan in dividends, with 251 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of Kanda's shareholders was 14,500, a decrease of 1.08% from the previous period. The average number of circulating shares per person increased by 2.23% to 9,266 shares [2]. - Notably, as of the same date, the fund "Baodao Yuanhang Mixed A" has exited the list of the top ten circulating shareholders [3]. Market Activity - On September 5, Kanda's stock price rose by 2.48%, reaching 12.79 yuan per share, with a trading volume of 13.748 million yuan and a turnover rate of 0.81%. The total market capitalization stood at 3.146 billion yuan [1]. - In terms of capital flow, there was a net inflow of 695,900 yuan from main funds, with significant buying activity from large orders [1].

Core Viewpoint - Tianyi New Materials reported a significant decline in revenue and negative net profit for the first half of 2025, indicating ongoing financial challenges for the company [1][2]. Financial Performance - The company's revenue for the first half of 2025 was 423 million yuan, a year-on-year decrease of 17.26% [1]. - The net profit attributable to shareholders was -209 million yuan, an increase of 57.52% compared to the previous year [1]. - The basic earnings per share were -0.37 yuan [1]. - The gross margin for the first half of 2025 was -4.88%, an increase of 14.60 percentage points year-on-year [2]. - The net margin was -49.58%, up 48.04 percentage points from the same period last year [2]. Quarterly Analysis - In Q2 2025, the gross margin was -10.67%, showing a year-on-year increase of 28.11 percentage points but a quarter-on-quarter decrease of 10.53 percentage points [2]. - The net margin for Q2 was -63.28%, which was an increase of 159.75 percentage points year-on-year but a decrease of 24.91 percentage points from the previous quarter [2]. Expense Management - Total operating expenses for the first half of 2025 were 173 million yuan, a decrease of 10.78 million yuan compared to the previous year [2]. - The expense ratio was 40.79%, an increase of 4.93 percentage points year-on-year [2]. - Sales expenses decreased by 9.83%, while management expenses increased by 13.97% [2]. Shareholder Information - As of the end of the first half of 2025, the total number of shareholders was 17,600, an increase of 1,090 or 6.61% from the previous quarter [3]. - The average market value per shareholder increased from 186,300 yuan to 205,100 yuan, a growth of 10.12% [3]. Company Overview - Tianyi New Materials specializes in the research, production, and sales of powder metallurgy brake pads for high-speed trains and urban rail vehicles [3]. - The main business revenue composition includes: 51.64% from photovoltaic monocrystalline auxiliary materials, 35.44% from powder metallurgy brake pads, and 12.13% from resin-based carbon fiber composite products [3]. - The company is categorized under the mechanical equipment industry, specifically in rail transit equipment [3].

Core Viewpoint - The stock price of Kanda has experienced fluctuations, with a year-to-date increase of 23.70% but a recent decline of 7.92% over the last five trading days [2]. Company Overview - Kanda Electronics Technology Co., Ltd. is located in Shenzhen, Guangdong Province, and was established on July 30, 1998, with its listing date on December 27, 2019 [2]. - The company specializes in providing products, services, and system solutions in the rail transit sector, with its main business revenue composition as follows: 64.63% from rail transit signal control systems, 23.90% from lightning protection and intelligent diagnosis, 6.64% from switch snow melting, 4.73% from system integration, and 0.11% from other sources [2]. Financial Performance - For the first half of 2025, Kanda achieved operating revenue of 160 million yuan, representing a year-on-year growth of 12.27%. However, the net profit attributable to shareholders decreased by 7.99% to 51.69 million yuan [2]. - Since its A-share listing, Kanda has distributed a total of 400 million yuan in dividends, with 251 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, Kanda had 14,500 shareholders, a decrease of 1.08% from the previous period, with an average of 9,266 circulating shares per person, an increase of 2.23% [2]. - Notably, as of June 30, 2025, the fund "Baodao Yuanhang Mixed A" (007126) has exited the list of the top ten circulating shareholders [3].

Group 1: Company Performance - XINWANDA reported a revenue of 26.985 billion yuan, a year-on-year increase of 12.82%, and a net profit of 856 million yuan, up 3.88% [1] - GUANGXUN TECHNOLOGY achieved a revenue of 5.243 billion yuan, a year-on-year increase of 68.59%, and a net profit of 372 million yuan, up 78.98% [1] - NORTHEAST SECURITIES posted a revenue of 2.046 billion yuan, a year-on-year increase of 31.66%, and a net profit of 431 million yuan, up 225.90% [1][2] - SHANXI COAL reported a revenue of 18.053 billion yuan, a year-on-year decrease of 16.30%, and a net profit of 1.014 billion yuan, down 48.44% [3] - SHENGTIAN NETWORK achieved a revenue of 633 million yuan, a year-on-year increase of 17.23%, and a net profit of 52.304 million yuan, up 1186.02% [4] - SANLIAN FORGING reported a revenue of 775 million yuan, a year-on-year increase of 6.86%, and a net profit of 71.335 million yuan, up 3.88% [5][6] - JIAMEI PACKAGING posted a revenue of 1.257 billion yuan, a year-on-year decrease of 8.73%, and a net profit of 19.7416 million yuan, down 65.59% [8] - ANZHENG FASHION achieved a revenue of 1.146 billion yuan, a year-on-year increase of 12.38%, and a net profit of 22.0834 million yuan, turning from a loss of 12.1096 million yuan in the previous year [9] - HUAHENG BIO reported a revenue of 1.489 billion yuan, a year-on-year increase of 46.54%, and a net profit of 115 million yuan, down 23.26% [10] - BAIREN MEDICAL achieved a revenue of 248 million yuan, a year-on-year increase of 30.07%, and a net profit of 71.4006 million yuan, up 102.90% [12] - TIANZHIHANG reported a revenue of 125 million yuan, a year-on-year increase of 114.89%, but a net loss of 57.5482 million yuan, worsening by 23.80% [14] - AIBO MEDICAL achieved a revenue of 787 million yuan, a year-on-year increase of 14.72%, and a net profit of 213 million yuan, up 2.53% [15] - ZHONGSHAN SHIPPING reported a revenue of 12.585 billion yuan, a year-on-year decrease of 4.91%, and a net profit of 2.125 billion yuan, down 14.91% [16] - SHANGHAI XINYANG achieved a revenue of 897 million yuan, a year-on-year increase of 35.67%, and a net profit of 133 million yuan, up 126.31% [17] - SHANCOAL INTERNATIONAL reported a revenue of 9.66 billion yuan, a year-on-year decrease of 31.28%, and a net profit of 655 million yuan, down 49.25% [18] - GUIDANCE reported a revenue of 935 million yuan, a year-on-year increase of 71.55%, and a net profit of 143 million yuan, turning from a loss of 48.9539 million yuan in the previous year [19] - YINGFANGWEI reported a revenue of 1.927 billion yuan, a year-on-year increase of 4.48%, but a net loss of 32.2966 million yuan, worsening from a loss of 22.4024 million yuan in the previous year [21] - CHINA COMMUNICATIONS reported a revenue of 14.665 billion yuan, a year-on-year increase of 2.91%, and a net profit of 1.621 billion yuan, up 1.34% [22] - CHINA GENERAL NUCLEAR reported a revenue of 39.167 billion yuan, a year-on-year decrease of 0.53%, and a net profit of 5.951 billion yuan, down 16.30% [23] - CHINA HEAVY TRUCK reported a revenue of 26.162 billion yuan, a year-on-year increase of 7.22%, and a net profit of 669 million yuan, up 8.10% [24] - SHENGGUANG GROUP achieved a revenue of 9.275 billion yuan, a year-on-year increase of 22.78%, and a net profit of 60.8446 million yuan, up 3.06% [25] Group 2: Dividend Proposals - XINWANDA proposed a cash dividend of 0.6 yuan per 10 shares [1] - SHANXI COAL proposed a cash dividend of 0.36 yuan per 10 shares [3] - ZHONGSHAN SHIPPING proposed a cash dividend of 0.7 yuan per 10 shares [16] - CHINA HEAVY TRUCK proposed a cash dividend of 3.15 yuan per 10 shares [24]

Core Viewpoint - China CNR Corporation's stock price has experienced fluctuations, with a recent decline of 2.05% and a year-to-date drop of 6.49%, despite a slight recovery in the past few trading days [1] Group 1: Stock Performance - As of August 27, the stock price was reported at 7.64 CNY per share, with a total market capitalization of 219.26 billion CNY [1] - The stock has seen a net outflow of 85.51 million CNY in principal funds, with significant selling pressure [1] - Year-to-date, the stock has decreased by 6.49%, but has increased by 3.66% over the last five trading days [1] Group 2: Financial Performance - For the first half of 2025, the company reported a revenue of 119.76 billion CNY, representing a year-on-year growth of 33.01% [2] - The net profit attributable to shareholders for the same period was 7.25 billion CNY, showing a significant increase of 72.48% year-on-year [2] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders was 513,200, a decrease of 1.20% from the previous period [3] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 81.08 million shares [3] - The company has distributed a total of 60.44 billion CNY in dividends since its A-share listing, with 17.51 billion CNY distributed in the last three years [3]

Group 1 - Tongda Power achieved a net profit of 42.64 million yuan in the first half of 2025, a year-on-year increase of 32.49% [1] - The company reported an operating income of 971 million yuan, up 22.07% year-on-year [1] - Basic earnings per share were 0.26 yuan [1] Group 2 - Hengshen New Materials reported a net loss of 36.70 million yuan in the first half of 2025, compared to a loss of 10.37 million yuan in the same period last year [2][3] - The company's operating income decreased by 24.84% to 1.22 billion yuan [2] Group 3 - Yiming Pharmaceutical's net profit was 37.56 million yuan, down 5.27% year-on-year [4] - The company experienced an 11.52% decline in operating income, totaling 311 million yuan [4] - Basic earnings per share were 0.20 yuan [4] Group 4 - Wangsu Technology achieved a net profit of 37.30 million yuan, a year-on-year increase of 25.33% [5] - The company's operating income was 2.35 billion yuan, up 2.19% year-on-year [5] - Basic earnings per share were 0.1524 yuan [5] Group 5 - Alloy Investment reported a net profit of 4.58 million yuan, a year-on-year increase of 44.12% [6] - The company achieved an operating income of 164 million yuan, up 73.46% year-on-year [6] - Basic earnings per share were 0.0119 yuan [6] Group 6 - Yifan Pharmaceutical's net profit was 30.40 million yuan, a year-on-year increase of 19.91% [8] - The company's operating income was 2.635 billion yuan, up 0.11% year-on-year [8] - Basic earnings per share were 0.25 yuan [8] Group 7 - Guoyao Yizhi reported a net profit of 66.60 million yuan, a year-on-year decrease of 10.43% [9] - The company's operating income was 36.797 billion yuan, down 2.62% year-on-year [9] - Basic earnings per share were 1.20 yuan [9] Group 8 - Hanjia Design expects a net profit of 15 to 16.5 million yuan, a year-on-year increase of 303.20% to 343.52% [10] - The company anticipates a net profit excluding non-recurring gains and losses of 14.5 to 17.5 million yuan, a year-on-year increase of 867.05% to 1067.13% [10] Group 9 - Gansu Energy Chemical announced the resumption of production at its Jinhe Coal Mine after passing safety inspections [16] Group 10 - Chuanjin Nuo reported a net profit of 177 million yuan, a year-on-year increase of 166.51% [18] - The company's operating income was 1.744 billion yuan, up 27.91% year-on-year [18] - Basic earnings per share were 0.6457 yuan [18] Group 11 - Yachuang Electronics achieved a net profit of 40.82 million yuan, a year-on-year increase of 1.47% [19] - The company's operating income was 2.847 billion yuan, up 125.74% year-on-year [19] - Basic earnings per share were 0.29 yuan [19] Group 12 - Yiheda reported a net profit of 282 million yuan, a year-on-year increase of 26.49% [14] - The company's operating income was 1.461 billion yuan, up 18.70% year-on-year [14] - Basic earnings per share were 0.44 yuan [14] Group 13 - Hatao Technology reported a net profit of 38 million yuan, a year-on-year increase of 233.08% [33] - The company's operating income was 1.475 billion yuan, up 1.12% year-on-year [33] - Basic earnings per share were 0.18 yuan [33] Group 14 - Anlu Technology announced that shareholders plan to reduce their holdings by no more than 3.25% of the company's shares [35] Group 15 - Baolidi reported a net profit of 63.81 million yuan, a year-on-year increase of 15.19% [36] - The company's operating income was 676 million yuan, up 1.47% year-on-year [36] - Basic earnings per share were 0.36 yuan [36] Group 16 - Harta Technology reported a net profit of 33.50 million yuan, a year-on-year increase of 55.61% [38] - The company's operating income was 335 million yuan, up 22.54% year-on-year [38] - Basic earnings per share were 0.0698 yuan [38] Group 17 - Huaxia Biological's controlling shareholder received a loan commitment of up to 250 million yuan from China Merchants Bank [58]

Group 1 - Shengde Xintai won a bid for a thermal power steel pipe project worth approximately 217 million yuan, accounting for 8.15% of its audited revenue for 2024 [1] - High-speed Electric's subsidiary won a project for the Shanghai-Nanjing-Hefei high-speed railway, with a bid amount of 71.76 million yuan [1] - Cangge Mining's subsidiary received a construction permit for a lithium-boron mining project, with a construction area of 106,900 square meters [2] Group 2 - China Electric Power Construction signed a mining transportation project contract in Guinea worth approximately 5.063 billion yuan, with a total duration of about 72 months [3] - Guobang Pharmaceutical's subsidiary completed the registration of an equity investment fund focusing on strategic emerging industries [4] - Deshi Co. obtained two invention patents related to oil and gas field development [5][26] Group 3 - Xue Tian Salt Industry expects a significant decrease in net profit for the first half of 2025, projecting a decline of 76.34% to 80.29% [6] - Rundu Co. received a drug registration certificate for moxifloxacin hydrochloride tablets, used for treating various bacterial infections [7] - China Nuclear Power reported a 15.65% increase in power generation in the first half of the year, with nuclear power generation up by 12.01% [8] Group 4 - Suqian Liansheng obtained two invention patents related to wastewater treatment methods [9] - Boshi Co. signed a 109 million yuan operation and maintenance service contract for solid product packaging [11] - *ST Sailong's subsidiary received a drug registration certificate for torasemide injection, used for various medical conditions [13] Group 5 - North Bay Port reported a 10.95% increase in cargo throughput for the first half of 2025, with container throughput also showing growth [14] - Kaiwei Te expects a revenue increase of 56.17% to 90.87% for the first half of 2025 [15] - Wankai New Materials plans to reduce production and conduct maintenance on 60,000 tons of PET capacity, affecting overall performance [16] Group 6 - Haiwang Bio's HW130 injection successfully completed Phase I clinical trials, showing good safety and tolerability [19] - Zhenai Meijia received a total of 22.8 million yuan in compensation for land acquisition, which will significantly impact its 2025 performance [20] - Changyuan Electric reported a 23.58% decrease in power generation in June, with a notable decline in thermal power generation [21] Group 7 - Shouxiangu's subsidiary completed the registration of two health food products [22] - Kailun Co. announced the resignation of its deputy general manager and board secretary [23] - Xibu Muye reported a 2.15% year-on-year increase in fresh milk production in June [24] Group 8 - Deshi Co. obtained two invention patents related to oil and gas field development [26] - Jingwei Huikai plans to acquire a 12.44% stake in Nuo Si Micro for 149 million yuan [27] - Electric Alloy completed the registration of its subsidiary in Mexico [29] Group 9 - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of 2025 [30] - Guizhou Moutai repurchased approximately 3.38 million shares, accounting for 0.2692% of its total share capital [31][32] - Warner Pharmaceutical received approval for the listing application of a raw material drug for treating respiratory diseases [34] Group 10 - Yuan Dong Bio's independent director is under investigation for serious violations [35] - Dash Intelligent signed a contract for a smart project worth 11.88 million yuan [36] - Dayou Energy plans to transfer 586,500 tons of coal production capacity replacement indicators [37] Group 11 - Foton Motor reported a 150.96% increase in new energy vehicle sales in the first half of 2025 [39] - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [40] - Zongshen Power expects a net profit increase of 70% to 100% for the first half of 2025 [42] Group 12 - Yingboer plans to sell its wholly-owned subsidiary for 239 million yuan [44] - Changan Automobile reported a 1.59% increase in total vehicle sales in the first half of 2025 [46] - Fulian Precision signed a cooperation framework agreement with Sichuan Development Longmang [48] Group 13 - Nengte Technology plans to repurchase shares worth 300 million to 500 million yuan [50] - Longsoft Technology's controlling shareholder donated 3.43% of the company's shares [51] - Data Port's shareholders plan to reduce their holdings by up to 2% [52]

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

Group 1 - China Communication Technology Co., Ltd. won a total of 11 important rail transit projects with a total bid amount of approximately 3.789 billion yuan, accounting for 11.67% of the company's audited revenue for 2024 [1] - New Chai Co., Ltd. plans to use no more than 500 million yuan of idle funds to purchase low-risk financial products to improve fund efficiency [2] - Qingshan Paper Industry's controlling shareholder intends to restructure and inject assets into Fujian Provincial Industrial Holding Group [3] Group 2 - BWS hired Liu Xiaodan as Senior Vice President, effective immediately [4] - Huakang Clean won a bid for a purification project at the Tengzhou Medical and Health Center, with a bid price of 60.2394 million yuan [6] - Silver Dragon Co., Ltd. announced that several executives plan to reduce their holdings by a total of no more than 550,000 shares due to personal financial needs [8] Group 3 - Intercontinental Oil & Gas plans to invest 848 million USD in the South Basra Integrated Project in Iraq, holding a 67% stake [13] - Huatai Dain's subsidiary received a drug registration certificate for sodium valproate oral solution, used for treating epilepsy [14] - Hainan Mining's 20,000-ton battery-grade lithium hydroxide project has achieved full-process connectivity and produced qualified products [29] Group 4 - Roman Co., Ltd.'s subsidiary won a significant overseas project in Saudi Arabia with a bid amount of approximately 200 million yuan [30] - Measurement Co., Ltd. completed a capital reduction for its subsidiary, optimizing resource allocation [31] - Guodian Nanzi plans to increase capital by 45 million yuan for its wholly-owned subsidiary to meet market expansion needs [32] Group 5 - Eighty Billion Space plans to repurchase shares with a total amount not less than 50 million yuan and not exceeding 100 million yuan [33] - Tianyin Electromechanical's director plans to reduce holdings of no more than 0.25% of the company's shares [34] - Hailier's subsidiary passed environmental protection acceptance for its agricultural chemical preparation project [35] Group 6 - Kelong Pharmaceutical's subsidiary will present innovative drug research results at the ASCO annual meeting [36] - Zhonghong Medical's subsidiary received medical device registration certificates for enteral nutrition pumps and injection pumps [37] - Luyou Pharmaceutical received a drug registration certificate for amlodipine besylate tablets, used for hypertension [39]